Key facts
- It has raised $2.2M; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include Creative Destruction Lab, Québec Tech, CancerX (USA), Adrian Schauer, AQC Capital — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Gray Oncology Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Gray Oncology Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gray Oncology Solutions
Developer of a healthcare resource allocation software intended to simplify cancer treatment logistics. The company develops an operating system that streamlines workflows across each oncological intervention and automates patient scheduling while incorporating the complex multi-disciplinary workflow, enabling healthcare workers to increase access to care, reduce patient wait times, increase patient/staff satisfaction, and improve patient care.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 9
- Website
- gray-os.com/
- Ownership
- Privately Held (backing)
Gray Oncology Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gray Oncology Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gray Oncology Solutions in its N-PORT filings yet. We sweep new filings monthly.